Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis

The human T-lymphotropic virus type-1 (HTLV-1) is an oncogenic retrovirus that predominantly spreads through cell-to-cell contact due to the limited infectivity of cell-free viruses. Among various modes of intercellular transmission, HTLV-1 biofilms emerge as adhesive structures, polarized at the ce...

Full description

Saved in:
Bibliographic Details
Main Authors: Coline Arone, Hélène Dutartre, Delphine Muriaux
Format: Article
Language:English
Published: Bio-protocol LLC 2024-12-01
Series:Bio-Protocol
Online Access:https://bio-protocol.org/en/bpdetail?id=5152&type=0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825206629691293696
author Coline Arone
Hélène Dutartre
Delphine Muriaux
author_facet Coline Arone
Hélène Dutartre
Delphine Muriaux
author_sort Coline Arone
collection DOAJ
description The human T-lymphotropic virus type-1 (HTLV-1) is an oncogenic retrovirus that predominantly spreads through cell-to-cell contact due to the limited infectivity of cell-free viruses. Among various modes of intercellular transmission, HTLV-1 biofilms emerge as adhesive structures, polarized at the cell surface, which encapsulate virions within a protective matrix. This biofilm is supposed to facilitate simultaneous virion delivery during infection. Yet, the molecular and functional intricacies of viral biofilms remain largely unexplored, despite their pivotal role in understanding retroviral pathogenesis. In this study, we optimized a protocol to isolate HTLV-1 biofilms from chronically infected T cells, facilitating their structural and molecular characterization using proteomic and super-resolution microscopy analyses. This protocol involves cultivating HTLV-1 chronically infected T cells at high density to facilitate the natural detachment of viral biofilms into the supernatant. Then, employing successive centrifugations, the cells are separated from the detached biofilms, and these structures are pelleted at medium speed (10,000× g). This method circumvents the need for mechanical, chemical, or enzymatic biofilm detachment, bypasses the use of ultracentrifugation, and enables us to resuspend the biofilms in the appropriate buffer for subsequent analyses such as western blotting or super-resolution microscopy imaging as presented.
format Article
id doaj-art-7f4a3c2494b44e38b8a0a0f08aab4187
institution Kabale University
issn 2331-8325
language English
publishDate 2024-12-01
publisher Bio-protocol LLC
record_format Article
series Bio-Protocol
spelling doaj-art-7f4a3c2494b44e38b8a0a0f08aab41872025-02-07T08:16:22ZengBio-protocol LLCBio-Protocol2331-83252024-12-01142410.21769/BioProtoc.5152Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity AnalysisColine Arone0Hélène Dutartre1Delphine Muriaux2Infectious Disease Research Institute of Montpellier (IRIM), UMR 9004 CNRS, University of Montpellier, Montpellier, FranceCenter for International Research on Infectiology (CIRI), UMR Inserm, ENS Lyon, Lyon, FranceInfectious Disease Research Institute of Montpellier (IRIM), UMR 9004 CNRS, University of Montpellier, Montpellier, FranceThe human T-lymphotropic virus type-1 (HTLV-1) is an oncogenic retrovirus that predominantly spreads through cell-to-cell contact due to the limited infectivity of cell-free viruses. Among various modes of intercellular transmission, HTLV-1 biofilms emerge as adhesive structures, polarized at the cell surface, which encapsulate virions within a protective matrix. This biofilm is supposed to facilitate simultaneous virion delivery during infection. Yet, the molecular and functional intricacies of viral biofilms remain largely unexplored, despite their pivotal role in understanding retroviral pathogenesis. In this study, we optimized a protocol to isolate HTLV-1 biofilms from chronically infected T cells, facilitating their structural and molecular characterization using proteomic and super-resolution microscopy analyses. This protocol involves cultivating HTLV-1 chronically infected T cells at high density to facilitate the natural detachment of viral biofilms into the supernatant. Then, employing successive centrifugations, the cells are separated from the detached biofilms, and these structures are pelleted at medium speed (10,000× g). This method circumvents the need for mechanical, chemical, or enzymatic biofilm detachment, bypasses the use of ultracentrifugation, and enables us to resuspend the biofilms in the appropriate buffer for subsequent analyses such as western blotting or super-resolution microscopy imaging as presented.https://bio-protocol.org/en/bpdetail?id=5152&type=0
spellingShingle Coline Arone
Hélène Dutartre
Delphine Muriaux
Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
Bio-Protocol
title Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
title_full Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
title_fullStr Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
title_full_unstemmed Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
title_short Isolation of Viral Biofilms From HTLV-1 Chronically Infected T Cells and Integrity Analysis
title_sort isolation of viral biofilms from htlv 1 chronically infected t cells and integrity analysis
url https://bio-protocol.org/en/bpdetail?id=5152&type=0
work_keys_str_mv AT colinearone isolationofviralbiofilmsfromhtlv1chronicallyinfectedtcellsandintegrityanalysis
AT helenedutartre isolationofviralbiofilmsfromhtlv1chronicallyinfectedtcellsandintegrityanalysis
AT delphinemuriaux isolationofviralbiofilmsfromhtlv1chronicallyinfectedtcellsandintegrityanalysis